Taken together, we suggest that LPA-induced keratinocyte proliferation could be one of the mechanisms underlying psoriasis development and combination therapy targeting LPAR1 and LPAR5 might be one of the options for psoriasis treatment. This evidence concerns the gene LPAR5 and psoriasis.